<p>随着美国市场连续第四个交易日上涨，受益于超出预期的 GDP 数据和强劲的科技行业表现，投资者越来越关注内部持股比例较高的成长型公司。在这种背景下，内部投资比例高的股票尤其吸引人，因为它们通常表明对公司未来前景的信心，尤其是在不断变化的经济环境中。</p>
<h3>美国内部持股比例高的十大成长型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>盈利增长</strong></td>
</tr>
<tr>
<td>超微计算机 (SMCI)</td>
<td>13.9%</td>
<td>50.7%</td>
</tr>
<tr>
<td>StubHub Holdings (STUB)</td>
<td>14.1%</td>
<td>74%</td>
</tr>
<tr>
<td>SES AI (SES)</td>
<td>12%</td>
<td>68.9%</td>
</tr>
<tr>
<td>Niu Technologies (NIU)</td>
<td>37.2%</td>
<td>93.7%</td>
</tr>
<tr>
<td>Credo Technology Group Holding (CRDO)</td>
<td>10.1%</td>
<td>30.7%</td>
</tr>
<tr>
<td>Corcept Therapeutics (CORT)</td>
<td>11.4%</td>
<td>52.7%</td>
</tr>
<tr>
<td>Bitdeer Technologies Group (BTDR)</td>
<td>33.4%</td>
<td>135.5%</td>
</tr>
<tr>
<td>Atour Lifestyle Holdings (ATAT)</td>
<td>18%</td>
<td>24.4%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>11.7%</td>
<td>29.0%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.4%</td>
<td>27.1%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们关于内部持股比例高的快速成长美国公司的 208 只股票的完整列表。</p>
<p>以下是筛选器中一些选择的简要介绍。</p>
<h2>ImmunityBio (IBRX)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> ImmunityBio, Inc. 是一家商业阶段的生物技术公司，专注于开发下一代疗法，以增强自然免疫系统对抗癌症和传染病，市值为 20.5 亿美元。</p>
<p><strong>运营：</strong> 该公司通过专注于开发增强免疫系统以对抗癌症和传染病的先进疗法，产生了 8256 万美元的收入。</p>
<p><strong>内部持股比例：</strong> 30%</p>
<p>ImmunityBio 拥有显著的内部持股，是一家专注于生物技术领域的成长型公司。最近的公告强调了 ANKTIVA® 在膀胱癌治疗中的潜力，得到了有希望的临床数据和欧洲监管进展的支持。该公司报告称 2025 年第三季度收入大幅增长至 3206 万美元，但面临负股本和现金流有限的挑战。尽管过去股东稀释，ImmunityBio 预计年收入增长 58.5%，高于市场平均水平，目标是在三年内实现盈利。</p>
<ul>
<li>点击这里了解 ImmunityBio 的细节，查看我们的详细分析未来增长报告。</li>
<li>我们的综合估值报告提出了 ImmunityBio 的股价可能低于其财务状况所能证明的水平。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b2d6e0fd-dc1f-4014-8f92-60363368b53b/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b2d6e0fd-dc1f-4014-8f92-60363368b53b/chart/ownership-breakdown"/></p>
<p>截至 2025 年 12 月 IBRX 的持股结构</p>
<h2>Uxin (UXIN)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Uxin Limited 是一家在中华人民共和国运营的二手车零售商，市值约为 7.03 亿美元。</p>
<p><strong>运营：</strong> Uxin 的收入主要来自其在中国作为二手车零售商的运营。</p>
<p><strong>内部持股比例：</strong> 37.3%</p>
<p>Uxin 拥有大量内部持股，正在扩展其在中国的二手车超级商店网络。最近在济南的开业和与天津和银川等新地点的战略合作伙伴关系突显了其增长战略。该公司预计 2025 年收入将超过 32 亿元人民币，反映出强劲的市场定位。Uxin 的收入预计将以每年 35.5% 的速度增长，超过美国市场平均增长率 10.7%。然而，该股票最近经历了高波动性。</p>
<ul>
<li>点击这里阅读我们的分析师估计报告，深入了解 Uxin 的表现。</li>
<li>我们的估值报告揭示了 Uxin 的股票可能以溢价交易的可能性。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d97cef4a-c4c1-4304-9530-9f3d25d77741/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d97cef4a-c4c1-4304-9530-9f3d25d77741/chart/earnings-and-revenue-growth"/></p>
<p>截至 2025 年 12 月 UXIN 的盈利和收入增长</p>
<h2>RH (RH)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> RH 及其子公司作为零售商和生活方式品牌，在美国、加拿大、英国、德国、比利时和西班牙的家居用品市场运营，市值约为 32.1 亿美元。</p>
<p><strong>运营：</strong> 该公司的收入主要来自其 Restoration Hardware (RH) 部门，产生 32.1 亿美元，以及其 Waterworks 部门，贡献 2 亿 002 万美元。</p>
<p><strong>内部持股比例：</strong> 16.7%</p>
<p>RH 显示出强劲的内部持股，管理层利益与股东一致。该公司报告称 2025 年第三季度盈利和收入均有所增加，净收入上升至 3627 万美元。尽管收入增长落后于更广泛的市场，RH 的盈利预计在未来三年将显著增长，年均增长率为 33.1%，超过美国市场平均水平。最近在底特律和曼哈塞特的扩张突显了其对沉浸式零售体验的承诺，可能增强长期增长前景。</p>
<ul>
<li>点击这里探索我们在 RH 盈利增长报告中的详细发现。</li>
<li>我们的综合估值报告提出了 RH 的股价可能高于其财务状况所能证明的水平。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ef6eec6a-cd7d-42a3-9b5b-224db638a3e7/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ef6eec6a-cd7d-42a3-9b5b-224db638a3e7/chart/earnings-and-revenue-growth"/></p>
<p>截至 2025 年 12 月 RH 的盈利和收入增长</p>
<h2>关键要点</h2>
<ul>
<li>点击这里解锁我们关于 208 家内部持股比例高的快速成长美国公司的综合列表。</li>
<li>寻找替代机会？发现下一个大机会，投资于财务稳健的低价股，平衡风险与回报。</li>
</ul>
<p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们提供的评论基于历史数据和分析师预测，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买卖任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
<p>国防和灾难的移动基础设施</p>
<p>下一波机器人技术不是类人型的。它是完全自主的塔，在 30 分钟内提供 5G、ISR 和雷达，随时随地。</p>
<p>在下一轮合同之前获取投资者简报</p>
<p>代表 CiTech 赞助</p>

优信

IBRX

<p>这篇文章强调了具有显著内部持股的成长型公司，表明对其未来前景的信心。值得注意的公司包括 ImmunityBio、Uxin 和 RH，它们都表现出强劲的内部持股和良好的增长预测。ImmunityBio 专注于生物技术疗法，Uxin 在中国扩展其二手车网络，而 RH 则提升零售体验。分析表明，这些公司可能在财务上被低估或高估，为寻求增长机会的投资者提供了洞察</p>

<p>As the U.S. market experiences a fourth consecutive session of gains, buoyed by better-than-expected GDP data and a strong tech sector performance, investors are increasingly focusing on growth companies with significant insider ownership. In this context, stocks with high levels of insider investment can be particularly appealing as they often indicate confidence in the company's future prospects amidst an evolving economic landscape.</p>
<div class="lb-trans"><p>随着美国市场连续第四个交易日上涨，受益于超出预期的 GDP 数据和强劲的科技行业表现，投资者越来越关注内部持股比例较高的成长型公司。在这种背景下，内部投资比例高的股票尤其吸引人，因为它们通常表明对公司未来前景的信心，尤其是在不断变化的经济环境中。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In The United States</h3>
<div class="lb-trans"><h3>美国内部持股比例高的十大成长型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>Super Micro Computer (SMCI)</td>
<td>13.9%</td>
<td>50.7%</td>
</tr>
<tr>
<td>StubHub Holdings (STUB)</td>
<td>14.1%</td>
<td>74%</td>
</tr>
<tr>
<td>SES AI (SES)</td>
<td>12%</td>
<td>68.9%</td>
</tr>
<tr>
<td>Niu Technologies (NIU)</td>
<td>37.2%</td>
<td>93.7%</td>
</tr>
<tr>
<td>Credo Technology Group Holding (CRDO)</td>
<td>10.1%</td>
<td>30.7%</td>
</tr>
<tr>
<td>Corcept Therapeutics (CORT)</td>
<td>11.4%</td>
<td>52.7%</td>
</tr>
<tr>
<td>Bitdeer Technologies Group (BTDR)</td>
<td>33.4%</td>
<td>135.5%</td>
</tr>
<tr>
<td>Atour Lifestyle Holdings (ATAT)</td>
<td>18%</td>
<td>24.4%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>11.7%</td>
<td>29.0%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.4%</td>
<td>27.1%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>盈利增长</strong></td>
</tr>
<tr>
<td>超微计算机 (SMCI)</td>
<td>13.9%</td>
<td>50.7%</td>
</tr>
<tr>
<td>StubHub Holdings (STUB)</td>
<td>14.1%</td>
<td>74%</td>
</tr>
<tr>
<td>SES AI (SES)</td>
<td>12%</td>
<td>68.9%</td>
</tr>
<tr>
<td>Niu Technologies (NIU)</td>
<td>37.2%</td>
<td>93.7%</td>
</tr>
<tr>
<td>Credo Technology Group Holding (CRDO)</td>
<td>10.1%</td>
<td>30.7%</td>
</tr>
<tr>
<td>Corcept Therapeutics (CORT)</td>
<td>11.4%</td>
<td>52.7%</td>
</tr>
<tr>
<td>Bitdeer Technologies Group (BTDR)</td>
<td>33.4%</td>
<td>135.5%</td>
</tr>
<tr>
<td>Atour Lifestyle Holdings (ATAT)</td>
<td>18%</td>
<td>24.4%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>11.7%</td>
<td>29.0%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.4%</td>
<td>27.1%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 208 stocks from our Fast Growing US Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>点击这里查看我们关于内部持股比例高的快速成长美国公司的 208 只股票的完整列表。</p>
</div><p>Here's a peek at a few of the choices from the screener.</p>
<div class="lb-trans"><p>以下是筛选器中一些选择的简要介绍。</p>
</div><h2>ImmunityBio (IBRX)</h2>
<div class="lb-trans"><h2>ImmunityBio (IBRX)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> ImmunityBio, Inc. is a commercial-stage biotechnology company focused on developing next-generation therapies to enhance the natural immune system against cancers and infectious diseases, with a market cap of $2.05 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> ImmunityBio, Inc. 是一家商业阶段的生物技术公司，专注于开发下一代疗法，以增强自然免疫系统对抗癌症和传染病，市值为 20.5 亿美元。</p>
</div><p><strong>Operations:</strong> The company generates revenue of $82.56 million from its focus on developing advanced therapies that enhance the immune system to combat cancers and infectious diseases.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司通过专注于开发增强免疫系统以对抗癌症和传染病的先进疗法，产生了 8256 万美元的收入。</p>
</div><p><strong>Insider Ownership:</strong> 30%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 30%</p>
</div><p>ImmunityBio, with significant insider ownership, is a growth-focused company in the biotech sector. Recent announcements highlight the potential of ANKTIVA® for bladder cancer treatment, supported by promising clinical data and European regulatory progress. The company reported substantial revenue growth to US$32.06 million in Q3 2025 but faces challenges with negative equity and limited cash runway. Despite past shareholder dilution, ImmunityBio's projected revenue growth of 58.5% annually positions it above market averages, aiming for profitability within three years.</p>
<div class="lb-trans"><p>ImmunityBio 拥有显著的内部持股，是一家专注于生物技术领域的成长型公司。最近的公告强调了 ANKTIVA® 在膀胱癌治疗中的潜力，得到了有希望的临床数据和欧洲监管进展的支持。该公司报告称 2025 年第三季度收入大幅增长至 3206 万美元，但面临负股本和现金流有限的挑战。尽管过去股东稀释，ImmunityBio 预计年收入增长 58.5%，高于市场平均水平，目标是在三年内实现盈利。</p>
</div><ul>
<li>Click here to discover the nuances of ImmunityBio with our detailed analytical future growth report.</li>
<li>Our comprehensive valuation report raises the possibility that ImmunityBio is priced lower than what may be justified by its financials.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里了解 ImmunityBio 的细节，查看我们的详细分析未来增长报告。</li>
<li>我们的综合估值报告提出了 ImmunityBio 的股价可能低于其财务状况所能证明的水平。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b2d6e0fd-dc1f-4014-8f92-60363368b53b/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/b2d6e0fd-dc1f-4014-8f92-60363368b53b/chart/ownership-breakdown"/></p>
<p>IBRX Ownership Breakdown as at Dec 2025</p>
<div class="lb-trans"><p>截至 2025 年 12 月 IBRX 的持股结构</p>
</div><h2>Uxin (UXIN)</h2>
<div class="lb-trans"><h2>Uxin (UXIN)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Uxin Limited is a used car retailer operating in the People's Republic of China with a market cap of approximately $703.04 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Uxin Limited 是一家在中华人民共和国运营的二手车零售商，市值约为 7.03 亿美元。</p>
</div><p><strong>Operations:</strong> Uxin's revenue is primarily generated from its operations as a used car retailer in China.</p>
<div class="lb-trans"><p><strong>运营：</strong> Uxin 的收入主要来自其在中国作为二手车零售商的运营。</p>
</div><p><strong>Insider Ownership:</strong> 37.3%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 37.3%</p>
</div><p>Uxin, with substantial insider ownership, is expanding its used car superstore network in China. Recent openings in Jinan and strategic partnerships for new locations like Tianjin and Yinchuan underscore its growth strategy. The company expects 2025 revenues to exceed RMB 3.2 billion, reflecting strong market positioning. Uxin's revenue is forecast to grow at 35.5% annually, surpassing the US market average growth rate of 10.7%. However, the stock has experienced high volatility recently.</p>
<div class="lb-trans"><p>Uxin 拥有大量内部持股，正在扩展其在中国的二手车超级商店网络。最近在济南的开业和与天津和银川等新地点的战略合作伙伴关系突显了其增长战略。该公司预计 2025 年收入将超过 32 亿元人民币，反映出强劲的市场定位。Uxin 的收入预计将以每年 35.5% 的速度增长，超过美国市场平均增长率 10.7%。然而，该股票最近经历了高波动性。</p>
</div><ul>
<li>Get an in-depth perspective on Uxin's performance by reading our analyst estimates report here.</li>
<li>Our valuation report unveils the possibility Uxin's shares may be trading at a premium.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里阅读我们的分析师估计报告，深入了解 Uxin 的表现。</li>
<li>我们的估值报告揭示了 Uxin 的股票可能以溢价交易的可能性。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d97cef4a-c4c1-4304-9530-9f3d25d77741/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/d97cef4a-c4c1-4304-9530-9f3d25d77741/chart/earnings-and-revenue-growth"/></p>
<p>UXIN Earnings and Revenue Growth as at Dec 2025</p>
<div class="lb-trans"><p>截至 2025 年 12 月 UXIN 的盈利和收入增长</p>
</div><h2>RH (RH)</h2>
<div class="lb-trans"><h2>RH (RH)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> RH, along with its subsidiaries, operates as a retailer and lifestyle brand in the home furnishings market across the United States, Canada, the United Kingdom, Germany, Belgium, and Spain with a market cap of approximately $3.21 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> RH 及其子公司作为零售商和生活方式品牌，在美国、加拿大、英国、德国、比利时和西班牙的家居用品市场运营，市值约为 32.1 亿美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its Restoration Hardware (RH) segment, generating $3.21 billion, and its Waterworks segment, contributing $200.02 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司的收入主要来自其 Restoration Hardware (RH) 部门，产生 32.1 亿美元，以及其 Waterworks 部门，贡献 2 亿 002 万美元。</p>
</div><p><strong>Insider Ownership:</strong> 16.7%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 16.7%</p>
</div><p>RH demonstrates strong insider ownership, aligning management interests with shareholders. The company reported increased earnings and revenue for Q3 2025, with net income rising to US$36.27 million. Despite revenue growth lagging behind the broader market, RH's earnings are forecast to grow significantly at 33.1% annually over the next three years, outpacing the US market average. Recent expansions in Detroit and Manhasset highlight its commitment to immersive retail experiences, potentially enhancing long-term growth prospects.</p>
<div class="lb-trans"><p>RH 显示出强劲的内部持股，管理层利益与股东一致。该公司报告称 2025 年第三季度盈利和收入均有所增加，净收入上升至 3627 万美元。尽管收入增长落后于更广泛的市场，RH 的盈利预计在未来三年将显著增长，年均增长率为 33.1%，超过美国市场平均水平。最近在底特律和曼哈塞特的扩张突显了其对沉浸式零售体验的承诺，可能增强长期增长前景。</p>
</div><ul>
<li>Click to explore a detailed breakdown of our findings in RH's earnings growth report.</li>
<li>Our comprehensive valuation report raises the possibility that RH is priced higher than what may be justified by its financials.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里探索我们在 RH 盈利增长报告中的详细发现。</li>
<li>我们的综合估值报告提出了 RH 的股价可能高于其财务状况所能证明的水平。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ef6eec6a-cd7d-42a3-9b5b-224db638a3e7/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/ef6eec6a-cd7d-42a3-9b5b-224db638a3e7/chart/earnings-and-revenue-growth"/></p>
<p>RH Earnings and Revenue Growth as at Dec 2025</p>
<div class="lb-trans"><p>截至 2025 年 12 月 RH 的盈利和收入增长</p>
</div><h2>Key Takeaways</h2>
<div class="lb-trans"><h2>关键要点</h2>
</div><ul>
<li>Unlock our comprehensive list of 208 Fast Growing US Companies With High Insider Ownership by clicking here.</li>
<li>Looking For Alternative Opportunities? Uncover the next big thing with financially sound penny stocks that balance risk and reward.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里解锁我们关于 208 家内部持股比例高的快速成长美国公司的综合列表。</li>
<li>寻找替代机会？发现下一个大机会，投资于财务稳健的低价股，平衡风险与回报。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们提供的评论基于历史数据和分析师预测，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买卖任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>国防和灾难的移动基础设施</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波机器人技术不是类人型的。它是完全自主的塔，在 30 分钟内提供 5G、ISR 和雷达，随时随地。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一轮合同之前获取投资者简报</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>代表 CiTech 赞助</p>
</div>

三家内部持股比例高达 37% 的成长型公司